Guanidinoacetic acid loading affects plasma γ-aminobutyric acid in healthy men
European Journal of Nutrition August 2015, Volume 54, Issue 5, pp 855-858 Sergej M. Ostojic
Guanidinoacetic acid (GAA), a precursor of creatine and an innovative dietary agent, activates γ-amino butyric acid (GABA) receptors yet clinical effects of dietary GAA on GABA metabolism are currently unknown. The main aim of this pilot research was to investigate whether GAA loading affected peripheral GABA homeostasis in healthy humans.
Eight healthy male volunteers aged 22–25 years were randomized in a double-blind design to receive either GAA (three grams daily) or placebo by oral administration for 3 weeks. At baseline and after 3 weeks participants provided fasting blood samples for free plasma levels of GABA, GAA, creatine and glutamine.
Following 3 weeks of intervention, plasma GABA level dropped significantly in participants receiving 3 g of GAA per day as compared to the placebo (P = 0.03). GAA loading significantly decreased plasma GABA by 88.8 nmol/L (95 % confidence interval; 5.4–172.1) after 3 weeks of intervention as compared to the baseline (P = 0.03). GAA intervention positively affected both plasma GAA and creatine (P
< 0.05), while no effects of intervention were reported for plasma glutamine.
Results indicate that supplemental
GAA affects peripheral GABA metabolism, and potentially down-regulates GABA synthesis in peripheral tissues. Possible GABAergic action of dietary GAA adds to the safety profile of this novel dietary supplement.
Voir aussi :
- Efficacité d'un supplément de GABA
- S’étouffer avec de la créatine, on arrête pas le progrès!
- La cystéine est-il le meilleur acide aminé pour réduire l'appétit?
- Effets de l' acide hyaluronique sur les tendons?
- Impacts de la créatine sur la sécrétion de testostérone